Sanofi (SNY) Total Non-Current Liabilities (2016 - 2025)
Sanofi's Total Non-Current Liabilities history spans 17 years, with the latest figure at $31.1 billion for Q4 2025.
- On a quarterly basis, Total Non-Current Liabilities rose 13.04% to $31.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $31.1 billion, a 13.04% increase, with the full-year FY2025 number at $31.1 billion, up 13.04% from a year prior.
- Total Non-Current Liabilities hit $31.1 billion in Q4 2025 for Sanofi, up from $29.0 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for SNY hit a ceiling of $35.9 billion in Q2 2021 and a floor of $27.5 billion in Q4 2024.
- Historically, Total Non-Current Liabilities has averaged $30.5 billion across 5 years, with a median of $30.0 billion in 2023.
- Biggest five-year swings in Total Non-Current Liabilities: fell 17.73% in 2022 and later rose 13.04% in 2025.
- Tracing SNY's Total Non-Current Liabilities over 5 years: stood at $34.2 billion in 2021, then fell by 17.73% to $28.2 billion in 2022, then grew by 6.64% to $30.0 billion in 2023, then dropped by 8.25% to $27.5 billion in 2024, then rose by 13.04% to $31.1 billion in 2025.
- Business Quant data shows Total Non-Current Liabilities for SNY at $31.1 billion in Q4 2025, $29.0 billion in Q2 2025, and $27.5 billion in Q4 2024.